1
/
of
0
FDA Drug Approval, A208569, TERIPARATIDE
FDA Drug Approval, A208569, TERIPARATIDE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
ANDA: 208569
Company: TEVA PHARMS USA
Drug Name: TERIPARATIDE
Active Ingredients: TERIPARATIDE
Strength: 0.6MG/2.4ML (0.25MG/ML)
Dosage Form/Route: SOLUTION;SUBCUTANEOUS
Action Date: 11/16/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP
Company: TEVA PHARMS USA
Drug Name: TERIPARATIDE
Active Ingredients: TERIPARATIDE
Strength: 0.6MG/2.4ML (0.25MG/ML)
Dosage Form/Route: SOLUTION;SUBCUTANEOUS
Action Date: 11/16/2023
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: AP
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details